http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120117196-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aaf127397fd5f114d8bfee1628e155e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_754d44d3d64fe3860a54299e8ffa9503 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac349901786a43f9d26dd651f94bf20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2329abb7eb6a987ca8ff851ddcc0a602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f910667f8451bc232645f034e991fce0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b50fba441a080bab6e606c980e7b16a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_535e5b7d225def08d409b60f6218d8d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7752d3a8e38b1a333616fe0037a88897 |
| publicationDate | 2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120117196-A |
| titleOfInvention | Composition for the prevention and treatment of hyperlipidemia, which contains the gilyeong fraction containing high purity of Praticoside as an active ingredient |
| abstract | The present invention relates to a composition for the prevention and treatment of hyperlipidemia using the Giltyeong fraction containing Praticoside as an active ingredient, and more particularly, to remove the precipitate formed by dissolving the Crude ethanol crude extract in ethanol and adding acetone. The concentrated citric ethanol-acetone fraction was dissolved in ethyl acetate, and the citric acid butanol fraction obtained by distributing water and saturated butanol sequentially was subjected to reverse phase (C18) cartridge chromatography using an ethanol-containing aqueous solution as an eluting solvent. The present invention relates to a composition for preventing and treating hyperlipidemia, which contains the isolated pathogenic fraction containing high purity of purified fricoside as an active ingredient. According to the present invention, by separating and purifying the Praticoside with high purity by a different method than the conventional method, the high content of Gilpyeong Praticoside and Praticodine D in the fraction is contained in high purity, blood by oral administration of the Gilpyeong extract and the Giltyeong fraction In addition, it can be expected to be used as a potential material with antihyperlipidemic activity and anti-arteriosclerosis activity by preventing the decomposition and digestion of triglycerides and lipids accumulated in cells and tissues and preventing the accumulation of cholesterol into liver tissue. have. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020159331-A1 |
| priorityDate | 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 247.